Otsuka Pharmaceutical Co., Ltd.
↗Tokyo, Japan
Otsuka Pharmaceutical is a leading global healthcare company and a core subsidiary of Otsuka Holdings Co., Ltd. The company is dedicated to the corporate philosophy of 'Otsuka-people creating new products for better health worldwide.' It operates two main pillars: a pharmaceutical business focused on addressing unmet medical needs and a nutraceutical business dedicated to maintaining everyday health.
In the pharmaceutical sector, Otsuka is a global leader in Central Nervous System (CNS) disorders, nephrology, and oncology. It is well-known for developing blockbuster treatments such as Abilify (aripiprazole) and Rexulti (brexpiprazole). The company has a significant global footprint, particularly in North America and Europe, and continues to expand through strategic acquisitions in biotechnology and digital health.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:CNS, Nephrology, and Oncology Therapeutics
SIZE & FINANCIALS
Employees:10000+
Revenue:$15.6B
Founded:1964
Ownership:subsidiary
Status:operating
FUNDING
Stage:Pre-IPO
STOCK
Exchange:TSE
Ticker:4578 (Parent: Otsuka Holdings)
Market Cap:$35.4B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, mAb, Digital Therapeutics, Antibody-drug conjugates (ADC), RNA
Active Trials:85
Trial Phases:Phase 1: 25 | Phase 2: 30 | Phase 3: 20 | Phase 4: 10
FDA Approvals:12
EMA Approvals:10
CORPORATE STRUCTURE
Parent Company:Otsuka Holdings Co., Ltd.
Subsidiaries:Otsuka America Pharmaceutical, Inc. (OAPI), Astex Pharmaceuticals, Visterra, Inc., Jnana Therapeutics, Taiho Pharmaceutical
Key Partnerships:Lundbeck (CNS collaboration for Rexulti/Abilify), ShapeTX (Ocular gene therapy), Cantargia (Autoimmune diseases)
COMPETITION
Position:Leader
Competitors:Takeda Pharmaceutical, Astellas Pharma, Eisai, Daiichi Sankyo, Eli Lilly
LEADERSHIP
Key Executives:
Makoto Inoue - President and Representative Director
Ichiro Otsuka - Chairman
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Otsuka Pharmaceutical Co., Ltd.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.